JLE

European Journal of Dermatology

MENU

Dyshidrosiform pemphigoid due to nivolumab therapy Volume 31, issue 3, May-June 2021

Figures


  • Figure 1
Authors
1 Department of Dermatology and Plastic Surgery,
2 Department of Gastroenterological Surgery, Akita University Graduate School of Medicine, Akita, 010-8543, Japan

Dyshidrosiform pemphigoid (DP) is regarded as a unique type of bullous pemphigoid (BP) with vesiculobullous eruptions localized to the palms and soles, which clinically resembles dyshidrosiform eczema. Some cases of BP due to programmed cell death protein-1 (PD-1) inhibitor have been reported. Here, we report a case of DP after the administration of the PD-1 inhibitor, nivolumab, with histopathological features that differ from those of idiopathic DP.A 69-year-old man had received chemotherapy for [...]